Om

Profusa Inc. Common Stock represents the equity of Profusa, Inc., a digital health and medical technology company based in Berkeley, California. Profusa develops bioengineered, body-integrated sensors designed to continuously detect and transmit clinical-grade data for personal and medical use. Its current product lineup includes the Lumee Oxygen Platform, which is used to monitor tissue oxygen levels in settings such as peripheral artery disease, chronic wounds, and reconstructive surgery, as well as the Lumee Glucose Platform, which is being developed to measure glucose levels in interstitial fluid. The company operates at the intersection of biosensing, medical devices, and digital health, serving applications in chronic disease management and real-time physiological monitoring. Profusa’s common stock provides public-market exposure to a company focused on continuous biomarker sensing technologies for healthcare professionals and patients.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I PROFUSA MED ENDAVU: Køb Profusa ($PFSA) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Profusa, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.